FDA Considers Comments From Industry On EUA Transition Guidance
Stakeholders across the medtech industry have submitted comments to the US Food and Drug Administration’s on its plans to help companies looking to keep their EUA products on the market post-pandemic.
You may also be interested in...
Draft legislation out of the US Senate Health, Education, Labor and Pensions (HELP) Committee gives the FDA authority to regulate certain in vitro diagnostics known as laboratory developed tests.
The US agency has issued an emergency use authorization to Labcorp for its over-the-counter test that detects COVID-19, flu and respiratory syncytial virus.
During the second global COVID-19 summit, US President Joe Biden pledged to share essential technologies across the globe to fight the pandemic.